Home › Research › Prevention and risk
Cardiovascular Disease Management and Prevention in Saudi Arabia: Strategies, Risk Factors, and Targeted Interventions
Aseel Awad Alsaidan. International Journal of Clinical Practice, 2025-01-01
Topic: Risk, prevention and care in population studies
Cardiovascular diseases (CVDs) remain the main cause of mortality and are generally among the leading causes of morbidity worldwide, thus placing an immense burden on health care. They include coronary artery disease, heart failure, hypertensive heart disease, and stroke. Among these, common risk factors include hypertension, high cholesterol, diabetes, smoking, obesity, and sedentary lifestyle. Yet, with advancements in medical science and pharmacology, these entities remain major challenges to public health worldwide. In Saudi Arabia, the rise in CVDs has been intensified by rapid urbanization and lifestyle changes and needs unique and tailored public health strategies. This review provides a comprehensive overview of the current situation with regard to cardiovascular health in Saudi Arabia, underlining the need for studying CVDs within the local context. It reviews the epidemiology of CVDs in the Kingdom of Saudi Arabia, outlining some of the major risk factors and also their impact on public health. This study also deals with the pharmacological approaches toward cardiovascular health by offering data from clinical trials so far completed, to point out effective strategies of treatment. The overview of prevention methods also includes public health initiatives, lifestyle programs, patient education, healthcare policies, the role of government initiatives, insurance coverage, and international collaborations. The review also elucidates the problems and barriers of the Saudi healthcare system, especially vis‐à‐vis the primary healthcare setting. In light of improving its healthcare sector, Saudi Arabia has embarked on several reforms within the Universal Health Coverage development initiative set in the framework of Vision 2030.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Alsaidan, A. A. (2025). Cardiovascular Disease Management and Prevention in Saudi Arabia: Strategies, Risk Factors, and Targeted Interventions. International Journal of Clinical Practice. https://doi.org/10.1155/ijcp/7233591
Vancouver
Alsaidan AA. Cardiovascular Disease Management and Prevention in Saudi Arabia: Strategies, Risk Factors, and Targeted Interventions. International Journal of Clinical Practice. 2025. doi:10.1155/ijcp/7233591.
BibTeX
@article{alsaidan2025-d3c9feab,
author = {Alsaidan, Aseel Awad},
title = {{Cardiovascular Disease Management and Prevention in Saudi Arabia: Strategies, Risk Factors, and Targeted Interventions}},
journal = {International Journal of Clinical Practice},
year = {2025},
doi = {10.1155/ijcp/7233591},
url = {https://doi.org/10.1155/ijcp/7233591}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- It reviews the epidemiology of CVDs in the Kingdom of Saudi Arabia, outlining some of the major risk factors and also their impact on public health.
- This study also deals with the pharmacological approaches toward cardiovascular health by offering data from clinical trials so far completed, to point out effective strategies of treatment.
- The overview of prevention methods also includes public health initiatives, lifestyle programs, patient education, healthcare policies, the role of government initiatives, insurance coverage, and international collaborations.
- The review also elucidates the problems and barriers of the Saudi healthcare system, especially vis‐à‐vis the primary healthcare setting.
- In light of improving its healthcare sector, Saudi Arabia has embarked on several reforms within the Universal Health Coverage development initiative set in the framework of Vision 2030.
Why it matters
This review describes cardiovascular disease epidemiology, risk factors, and prevention strategies in Saudi Arabia. It does not address Alzheimer's disease.
New to this subject? Start with our plain-English guide: Prevention →
Study details
- Evidence strengthLow
How this study scored 38/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomised / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (International Journal of Clinical Practice) |
| Journal's citation record | 1 / 4 | International Journal of Clinical Practice: journal h-index 142 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomised / blinded | 0 / 2 | No randomisation or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 3 / 7 | Cited 20 times (OpenAlex, 2026-10-10) |
| Citations per year | 2 / 5 | 6.7 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 4 / 6 | Cited 13.0× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 2 / 4 | Cited 20 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 1 / 4 | Last-listed author Aseel Awad Alsaidan: h-index 10 (OpenAlex, whole career) |
| Institution's track record | 0 / 3 | Jouf University: institution h-index 170 (OpenAlex) |
| Multi-centre collaboration | 0 / 3 | OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 1 / 2 | Not in PubMed, but has a DOI |
| Free to read | 2 / 2 | Free to read |
| Total | 38 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1155/ijcp/7233591
- Original source →
- Free full text: International Journal of Clinical Practice →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related studies in Prevention and risk
Also in Prevention and risk
265 studies in the library are filed under Prevention and risk with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Prevention and risk hub.